adding to your comments, Jeffery friedland told me on the phone-awhile back- that the multiple myeloma treatment would be a 250 million dollar market cap(sustainable) once it reached orphan drug status.. this may take some time, yet, with all the catalysts that owcp will have, the o/s, imo, as compared to gwph, will not be as much a factor-with much more diversity that owcp will have...

maybe gwph and owcp can end up working together, but another big co. may be better... like, Pfizer...

looking forward to pr's and 8k's to end speculation... I can wait for them.. glta...